Serum amyloid A3 does not contribute to circulating SAA levels

Journal of Lipid Research

Volumn 50, Issue 7, 2009, Pages 1353-1362

  Chiba, Tsuyoshi ^a,b,d   Han, Chang Yeop ^a,c   Valsar, Tomas ^a,c   Shimokado, Kentaro ^b   Kargi, Atil ^a   Chen, Mei Hsiu ^a   Wang, Shari ^a,c   McDonald, Thomas O ^a   O'Brien, Kevin D ^a   Heinecke, Jay W ^a,c   Chait, Alan ^a,c  

^a Department of Medicine   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Adipose tissue; ApoE deficient mice; Gene expression; HDL; Local inflammation; Ob ob mice; Obesity; Systemic inflammation

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; SERUM AMYLOID A; SERUM AMYLOID A3; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; HYPERLIPIDEMIA; INTRAABDOMINAL FAT; LIVER METABOLISM; MALE; MASS SPECTROMETRY; MOUSE; MOUSE MUTANT; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; UPREGULATION;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEINS E; CHOLESTEROL; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; OBESITY; SERUM AMYLOID A PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 67650531437     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M900089-JLR200     Document Type: Article

References (51)

1. Matsuzawa, Y., T. Nakamura, I. Shimomura, and K. Kotani. 1995. Visceral fat accumulation and cardiovascular disease. Obes. Res. 3 (Suppl 5): 645S-647S.
2. Fujimoto, W. Y., S. E. Kahn, and J. D. Brunzell. 1994. Metabolic basis for coronary artery disease risk in central obesity and glucose intolerance. In Multiple Risk Factors in Cardiovascular Disease: The Second Symposium Proceedings. A. Yamamoto, editor. Churchill Livingstone, Tokyo. 189-192.
3. Guzik, T. J., D. Mangalat, and R. Korbut. 2006. Adipocytokines - novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57: 505-528.
4. Matsuzawa, Y. 2005. Adipocytokines and metabolic syndrome. Semin. Vasc. Med. 5: 34-39.
5. Libby, P., and P. M. Ridker. 2004. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med. 116(Suppl 6A): 9S-16S.
6. Johnson, B. D., K. E. Kip, O. C. Marroquin, P. M. Ridker, S. F. Kelsey, L. J. Shaw, C. J. Pepine, B. Sharaf, C. N. Bairey Merz, G. Sopko, et al. 2004. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 109: 726-732.
7. Vidal, H. 2003. Obesity and inflammation: the adipocytokines. [French] Ann. Endocrinol. (Paris). 64: S40-S44.
8. Leinonen, E. S., A. Hiukka, E. Hurt-Camejo, O. Wiklund, S. S. Sarna, L. Mattson Hulten, J. Westerbacka, R. M. Salonen, J. T. Salonen, and M. R. Taskinen. 2004. Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes. J. Intern. Med. 256: 119-127.
9. Dandona, P., A. Aljada, and A. Bandyopadhyay. 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25: 4-7.
10. McCarty, M. F. 1999. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses. 52: 465-477.
11. van Dielen, F. M., C. van't Veer, A. M. Schols, P. B. Soeters, W. A. Buurman, and J. W. Greve. 2001. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int. J. Obes. Relat. Metab. Disord. 25: 1759-1766.
12. Szalai, A. J. 2002. The biological functions of C-reactive protein. Vascul. Pharmacol. 39: 105-107.
13. Szalai, A. J., and M. A. McCrory. 2002. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunol. Res. 26: 279-287.
14. Subramanian, S., C. Y. Han, T. Chiba, T. S. McMillen, S. A. Wang, A. Haw, III, E. A. Kirk, K. D. O'Brien, and A. Chait. 2008. Dietary Cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28: 685-691.
15. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
16. Lewis, K. E., E. A. Kirk, T. O. McDonald, S. Wang, T. N. Wight, K. D. O'Brien, and A. Chait. 2004. Increase in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation. 110: 540-545.
17. Benditt, E. P., N. Eriksen, and R. H. Hanson. 1979. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 76: 4092-4096.
18. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M. S. Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J. Biol. Chem. 261: 9644-9651.
19. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523.
20. Jorgensen, J. B., H. Lunde, L. Jensen, A. S. Whitehead, and B. Robertsen. 2000. Serum amyloid A transcription in Atlantic salmon
21. (Salmo salar L.) hepatocytes is enhanced by stimulation with macrophage factors, recombinant human IL-1 beta, IL-6 and TNF alpha or bacterial lipopolysaccharide. Dev. Comp. Immunol. 24: 553-563.
22. Leinonen, E., E. Hurt-Camejo, O. Wiklund, L. M. Hulten, A. Hiukka, and M. R. Taskinen. 2003. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 166: 387-394.
23. Poitou, C., N. Viguerie, R. Cancello, R. De Matteis, S. Cinti, V. Stich, C. Coussieu, E. Gauthier, M. Courtine, J. D. Zucker, et al. 2005. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia. 48: 519-528.
24. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808.
25. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.
26. Meek, R. L., and E. P. Benditt. 1986. Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164: 2006-2017.
27. Kluve-Beckerman, B., M. L. Drumm, and M. D. Benson. 1991. Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol. 10: 651-661.
28. Sjoholm, K., J. Palming, L. E. Olofsson, A. Gummesson, P. A. Svensson, T. C. Lystig, E. Jennische, J. Brandberg, J. S. Torgerson, B. Carlsson, et al. 2005. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J. Clin. Endocrinol. Metab. 90: 2233-2239.
29. Fain, J. N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74: 443-477.
30. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
31. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
32. Coleman, D. L. 1978. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 14: 141-148.
33. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372: 425-431.
34. Green, H., and M. Meuth. 1974. An established pre-adipose cell line and its differentiation in culture. Cell. 3: 127-133.
35. Su, S. B., W. Gong, J. L. Gao,W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
36. Han, C. Y., S. Subramanian, C. K. Chan, M. Omer, T. Chiba, T. N. Wight, and A. Chait. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes. 56: 2260-2273.
37. Mendez, A. J., J. F. Oram, and E. L. Bierman. 1991. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266: 10104-10111.
38. Han, C. Y., T. Chiba, J. S. Campbell, N. Fausto, M. Chaisson, G. Orasanu, J. Plutzky, and A. Chait. 2006. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26: 1806-1813.
39. Zizola, C. F., V. Julianelli, G. Bertolesi, M. Yanagishita, and J. C. Calvo. 2007. Role of versican and hyaluronan in the differentiation of 3T3-L1 cells into preadipocytes and mature adipocytes. Matrix Biol. 26: 419-430.
40. Smas, C. M., and H. S. Sul. 1995. Control of adipocyte differentiation. Biochem. J. 309: 697-710.
41. Allingham, P. G., G. R. Brownlee, G. S. Harper, M. Pho, S. K. Nilsson, and T. J. Brown. 2006. Gene expression, synthesis and degradation of hyaluronan during differentiation of 3T3-L1 adipocytes. Arch. Biochem. Biophys. 452: 83-91.
42. Bouloumie, A., C. A. Curat, C. Sengenes, K. Lolmede, A. Miranville, and R. Busse. 2005. Role of macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab. Care. 8: 347-354.
43. Fantuzzi, G. 2005. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115: 911-919 (quiz 920).
44. Suganami, T., J. Nishida, and Y. Ogawa. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25: 2062-2068.
45. Kamei, N., K. Tobe, R. Suzuki, M. Ohsugi, T. Watanabe, N. Kubota, N. Ohtsuka-Kowatari, K. Kumagai, K. Sakamoto, M. Kobayashi, et al. 2006. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281: 26602-26614.
46. Lebovitz, H. E. 2006. Insulin resistance - a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes. Metab. 8: 237-249.
47. Kanda, H., S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, et al. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116: 1494-1505.
48. Inouye, K. E., H. Shi, J. K. Howard, C. H. Daly, G. M. Lord, B. J. Rollins, and J. S. Flier. 2007. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes. 56: 2242-2250.
49. Kirk, E. A., Z. K. Sagawa, T. O. McDonald, K. D. O'Brien, and J. W. Heinecke. 2008. Macrophage chemoattractant protein-1 deficiency fails to restrain macrophage infiltration into adipose tissue. Diabetes. 57: 1254-1261.
50. Hatanaka, E., P. T. Monteagudo, M. S. Marrocos, and A. Campa. 2007. Interaction between serum amyloid A and leukocytes - a possible role in the progression of vascular complications in diabetes. Immunol. Lett. 108: 160-166.
51. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180: 203-209.